home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/d648b4d6-8780-4494-bb74-f8f0da0bafc3_MAET_DDC_WHITEPAPER_JUNE2019.pdf
whitepaper
SHARESHARESHARE
IMPACT ON COMBINATION PRODUCTS AND COMPANION DIAGNOSTICS
With the end of the Medical Device Regulation’s (MDR) transition period looming (May 26th, 2020), manufacturers of drug device combination products or companion diagnostics are under heightened time pressure to comply with the new Regulation. Any company manufacturing or distributing these products risks losing European market access unless their products meet the latest regulatory requirements. DOWNLOAD